Literature DB >> 27531533

Recent "omics" advances in Helicobacter pylori.

Elvire Berthenet1, Sam Sheppard2, Filipa F Vale3.   

Abstract

The development of high-throughput whole genome sequencing (WGS) technologies is changing the face of microbiology, facilitating the comparison of large numbers of genomes from different lineages of a same organism. Our aim was to review the main advances on Helicobacter pylori "omics" and to understand how this is improving our knowledge of the biology, diversity and pathogenesis of H. pylori. Since the first H. pylori isolate was sequenced in 1997, 510 genomes have been deposited in the NCBI archive, providing a basis for improved understanding of the epidemiology and evolution of this important pathogen. This review focuses on works published between April 2015 and March 2016. Helicobacter "omics" is already making an impact and is a growing research field. Ultimately these advances will be translated into a routine clinical laboratory setting in order to improve public health.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  genetic admixture; genomics and transcriptomics; mobile elements; pathogenicity islands; target new therapy

Mesh:

Year:  2016        PMID: 27531533     DOI: 10.1111/hel.12334

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  3 in total

Review 1.  Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data.

Authors:  Joana S Vital; Luís Tanoeiro; Ricardo Lopes-Oliveira; Filipa F Vale
Journal:  Biomolecules       Date:  2022-05-11

2.  Analysis of genetic recombination and the pan-genome of a highly recombinogenic bacteriophage species.

Authors:  Koji Yahara; Philippe Lehours; Filipa F Vale
Journal:  Microb Genom       Date:  2019-07-16

Review 3.  Relating Phage Genomes to Helicobacter pylori Population Structure: General Steps Using Whole-Genome Sequencing Data.

Authors:  Filipa F Vale; Philippe Lehours
Journal:  Int J Mol Sci       Date:  2018-06-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.